Soleus Capital Management »

Biodesix shares owned by Soleus Capital Management

Quarter-by-quarter ownership of Biodesix (BDSX) shares owned by Soleus Capital Management from 13F filings

Historical chart of Soleus Capital Management investment in Biodesix

Tip: Access up to 7 years of quarterly data

All positions including Biodesix held by Soleus Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biodesix by Soleus Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $9.4M 6.1M 1.53

More positions owned by Soleus Capital Management

Tg Therapeutics (TGTX)
Iovance Biotherapeutics (IOVA)
United Therapeutics Corporation (UTHR)
Nurix Therapeutics (NRIX)
Edap Tms S A Sponsored Adr (EDAP)
Terns Pharmaceuticals (TERN)
Revolution Medicines (RVMD)
SurModics (SRDX)
Organogenesis Hldgs (ORGO)
Jasper Therapeutics Com New (JSPR)
Ideaya Biosciences (IDYA)
Axogen (AXGN)
Krystal Biotech (KRYS)
Merus N V (MRUS)
Penumbra (PEN)

View all positions for Soleus Capital Management

Top funds holding Biodesix

Telemark Asset Management
Soleus Capital Management
Bryn Mawr Trust
AIGH Capital Management
Birchview Capital
Sio Capital Management
Opaleye Management
Monashee Investment Management
Vanguard Group
Perceptive Advisors
Farallon Capital Management
Silverarc Capital Management
Essex Investment Management
Wells Fargo & Company
Geode Capital Management

View all funds holding Biodesix